Patents by Inventor Sun-hee Kim

Sun-hee Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12082671
    Abstract: The present invention is directed to a suitcase which is made of a metal material such as aluminum or made of synthetic resin or fabric, is formed in a quadrangular shape, and is provided with a zipper or one-touch locking device along a center thereof so that a suitcase body can be selectively opened and closed, and in which a handle is installed to be retractable on the top surface of the suitcase body, wherein an auxiliary moving means configured such that auxiliary casters are rotated and deployed by the extension of a handle is installed on the suitcase body so that the suitcase body can be laid down and moved, and a loading guide is installed to be foldable on the suitcase body so that a load can be loaded thereonto in the state where the suitcase body is laid down.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: September 10, 2024
    Inventor: Sun Hee Kim
  • Patent number: 12048296
    Abstract: The present disclosure relates to an aglycosylated antibody-producing transgenic mouse and the use of an aglycosylated antibody produced therefrom. When the transgenic mouse of the present disclosure is used, it is possible to easily produce aglycosylated antibodies against various target antigens, and to precisely diagnose disease by detecting a glycoprotein biomarker using the produced aglycosylated antibody.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: July 30, 2024
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Yong Sam Kim, Jeong Heon Ko, Nan Ee Lee, Sun Hee Kim
  • Publication number: 20240109866
    Abstract: Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
    Type: Application
    Filed: June 1, 2023
    Publication date: April 4, 2024
    Inventors: Sangdon HAN, Yunfei ZHU, Sun Hee KIM, Jian ZHAO, Shimiao WANG
  • Publication number: 20240024297
    Abstract: A method for preventing or treating renal ischemia reperfusion injury or acute kidney injury associated with renal ischemia reperfusion injury in a subject in need thereof includes administering to the subject a therapeutically effective amount of a 15-PGDH inhibitor.
    Type: Application
    Filed: March 29, 2023
    Publication date: January 25, 2024
    Inventors: Sanford Markowitz, Ki Beom Bae, Hye Jung Kim, Sun-Hee Kim
  • Publication number: 20230405157
    Abstract: Described herein are radiotherapeutics that target tumor cells expressing the melanocortin type 2 receptor (MC2R) and their use in the treatment and/or diagnosis of cancer.
    Type: Application
    Filed: May 8, 2023
    Publication date: December 21, 2023
    Inventors: Jian ZHAO, Mi CHEN, Yunfei ZHU, Sun Hee KIM
  • Patent number: 11834462
    Abstract: Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: December 5, 2023
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Sangdon Han, Sun Hee Kim, Yunfei Zhu
  • Patent number: 11795447
    Abstract: Disclosed is a method for extracting high-purity polydeoxyribonucleotide (PDRN) from salmon testes, including 1) separating semen and immature testicular regions from the testes of a salmonid fish, 2) gently grinding the immature testicular regions, followed by dilution with an artificial seminal plasma, 3) treating the dilution with a predetermined concentration of human chorionic gonadotropin (hCG) to induce artificial sexual maturation of the testicular cells to sperm, 4) centrifuging the testicular dilution after the passage of a predetermined time from the hCG treatment and collecting potentially motile sperm, and 5) extracting PDRN from the collected sperm. The method enables the production of raw materials for PDRN with a 100- to 200-fold higher purity from 20 mL (a maximum of 50 mL) of sperm (semen) collected at one time from a salmonid fish. In addition, the method enables the extraction of PDNR in high yield in a cost-effective and economically viable manner.
    Type: Grant
    Filed: August 12, 2021
    Date of Patent: October 24, 2023
    Assignee: BIO MEDI PHARM CO. LTD.
    Inventors: O Nam Kwon, Tae-hyun Kim, Sun-hee Kim
  • Publication number: 20230270217
    Abstract: The present invention is directed to a suitcase which is made of a metal material such as aluminum or made of synthetic resin or fabric, is formed in a quadrangular shape, and is provided with a zipper or one-touch locking device along a center thereof so that a suitcase body can be selectively opened and closed, and in which a handle is installed to be retractable on the top surface of the suitcase body, wherein an auxiliary moving means configured such that auxiliary casters are rotated and deployed by the extension of a handle is installed on the suitcase body so that the suitcase body can be laid down and moved, and a loading guide is installed to be foldable on the suitcase body so that a load can be loaded thereonto in the state where the suitcase body is laid down.
    Type: Application
    Filed: October 1, 2021
    Publication date: August 31, 2023
    Inventor: Sun Hee KIM
  • Publication number: 20230257349
    Abstract: The present invention relates to certain substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.
    Type: Application
    Filed: August 11, 2022
    Publication date: August 17, 2023
    Inventors: Robert M. Jones, Daniel J. Buzard, Sangdon Han, Sun Hee Kim, Juerg Lehmann, Brett Ullman, Jeanne V. Moody, Xiuwen Zhu, Scott Stirn
  • Patent number: 11685844
    Abstract: A polysiloxane is prepared by hydrosilylation reaction of a polyorganosilicate resin and an SiH terminated polydiorganosiloxane. The polysiloxane acts as a controlled release additive when formulated into a release coating composition. The release coating composition can be coated on a surface of a substrate and cured to form a release liner.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: June 27, 2023
    Assignee: DOW SILICONES CORPORATION
    Inventors: Sun Hee Kim, Jeong Gi Kim
  • Patent number: 11662603
    Abstract: The three-dimensional image display apparatus includes: a housing; a light source unit which is mounted in the housing, and emits light; a single light transfer unit which is disposed in the housing to face the light source unit, and refracts, diffracts, or reflects the light emitted from the light source unit; and an image display unit which forms, as an image, the light refracted, diffracted, or reflected by the light transfer unit.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: May 30, 2023
    Assignee: HYUNDAI MOBIS CO., LTD.
    Inventors: Gil Won Han, Sun Hee Kim
  • Publication number: 20230135560
    Abstract: Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
    Type: Application
    Filed: December 11, 2020
    Publication date: May 4, 2023
    Inventors: Sangdon HAN, Sun Hee KIM, Yunfei ZHU
  • Publication number: 20230126662
    Abstract: Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
    Type: Application
    Filed: December 10, 2020
    Publication date: April 27, 2023
    Inventors: Sangdon HAN, Sun Hee KIM, Yunfei ZHU
  • Publication number: 20230052363
    Abstract: A method for preventing or treating renal disorder, disease, and/or injury includes administering to the subject and/or kidney a therapeutically effective amount of a 15-PGDH inhibitor.
    Type: Application
    Filed: August 22, 2022
    Publication date: February 16, 2023
    Inventors: SANFORD MARKOWITZ, SUN-HEE KIM, HYE JUNG KIM, KIBEOM BAE
  • Patent number: 11566015
    Abstract: Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: January 31, 2023
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Sangdon Han, Yunfei Zhu, Sun Hee Kim, Jian Zhao, Shimiao Wang
  • Publication number: 20230022513
    Abstract: Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: April 6, 2022
    Publication date: January 26, 2023
    Inventors: Sangdon HAN, Sun Hee KIM, Yunfei ZHU
  • Publication number: 20230015914
    Abstract: Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
    Type: Application
    Filed: October 30, 2020
    Publication date: January 19, 2023
    Inventors: Sangdon HAN, Sun Hee KIM, Yunfei ZHU
  • Publication number: 20220380337
    Abstract: Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: July 1, 2022
    Publication date: December 1, 2022
    Inventors: Jian ZHAO, Sangdon HAN, Sun Hee KIM, Shimiao WANG, Yunfei ZHU
  • Patent number: 11485888
    Abstract: A silicone pressure-sensitive adhesive composition is disclosed. The composition can be cured into a pressure-sensitive adhesive having a good release force against a release liner and a high peel force against several substrates. The silicone pressure-sensitive adhesive composition comprises: (A) a diorganopolysiloxane having on average at least 0.5 alkenyl groups with 2 to 12 carbon atoms per molecule; (B) an organopolysiloxane composed of R13SiO1/2 and SiO4/2 units, wherein each R1 represents a monovalent hydrocarbon group with 1 to 12 carbon atoms, having a molar ratio (R13SiO1/2 unit)/(SiO4/2 unit) of 0.6 to 1.7, and having a number average molecular weight (Mn) converted to standard polystyrene of from 1,700 to 3,000; (C) an organohydrogenpolysiloxane having on average at least two silicon-bonded hydrogen atoms per molecule; and (D) a hydrosilylation catalyst.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: November 1, 2022
    Assignee: DOW SILICONES CORPORATION
    Inventors: Ho-Jin Choi, Sun-Hee Kim, Min-Cheol Jeon
  • Patent number: 11414397
    Abstract: Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: August 16, 2022
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Jian Zhao, Sangdon Han, Sun Hee Kim, Shimiao Wang, Yunfei Zhu